Rapport Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $721k | 24k | 29.70 |
| 2025-06-30 | $284k | 25k | 11.37 |
| 2025-03-31 | $144k | 14k | 10.03 |
| 2024-12-31 | $182k | 10k | 17.74 |
| 2024-09-30 | $325k | 16k | 20.48 |